相关实验视频

Updated: Jun 11, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌免疫检查点治疗的进展

Yamei Huang¹, Weiping Yu¹

¹Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China.

British journal of hospital medicine (London, England : 2005)

|September 30, 2024

概括

肝细胞癌 (HCC) 治疗面临的挑战是由于免疫逃避. 本综述探讨了HCC的免疫逃避机制,以提高免疫检查点治疗的疗效和患者的生存率.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

肝细胞癌 (HCC) 的发病率和死亡率正在上升,传统疗法管理不善的晚期癌症.
免疫检查点疗法在各种癌症中表现有前途,但在HCC中具有可变的疗效.
免疫逃避,特别是免疫细胞透不足,是限制HCC免疫检查点治疗反应的关键因素.

研究的目的:

在免疫检查点治疗期间审查肝细胞癌中免疫逃避的机制.
讨论未来克服免疫逃避和增强治疗疗效的策略.

主要方法:

在HCC中对免疫逃避机制的文献综述.
在癌症免疫疗法中对免疫抵抗有助于免疫抵抗的因素的分析.

主要成果:

免疫逃避显著阻碍了HCC患者免疫检查点抑制剂的有效性.
免疫细胞透不足是治疗反应不佳的主要驱动因素.
了解这些机制对于开发更有效的治疗方法至关重要.

结论:

克服免疫逃避对于改善接受免疫治疗的HCC患者的治疗结果至关重要.
准免疫逃避途径可能会提高免疫检查点治疗的有效性.
对免疫逃避机制的进一步研究可以提高HCC患者的生存率.

关键词:

肝细胞癌 (HCC) 是一种肝细胞癌.免疫检查点治疗疗法免疫检查点治疗免疫逃避免疫逃避

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...